We need to stigmatize treatment of chronic conditions with pharmaceuticals. To ensure repeat business only symptoms get treated, never the underlying problem, and that's been the business model for a very long time. Acute, singular troubles may still require pharmaceutical assistance, but they should be restricted short-term, well-controlled applications accompanied by dietary advice.